NCT00907933View on ClinicalTrials.gov

Intranasal SB-705498 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

November 10, 2008

Primary Completion Date

February 11, 2009

Study Completion Date

February 11, 2009

Conditions
Rhinitis
Interventions
DRUG

SB-705498

0.5mg intranasal SB-705498

DRUG

SB-705498

1.5mg intranasal SB-705498

DRUG

SB-705498

3mg intranasal SB-705498

DRUG

SB-705498

6mg intranasal SB-705498

DRUG

SB-705498

12mg intranasal SB-705498

DRUG

Placebo

Placebo '498

DRUG

SB-705498

6mg intranasal SB-705498 for 14 days bid

DRUG

SB-705498

12mg intranasal SB-705498 14 days bid

DRUG

Placebo

Placebo

Trial Locations (1)

NW10 7EW

GSK Investigational Site, London

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY